Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

440 ARTíCULOS , VIENDO DEL 286 AL 300

PUBMED

[The marginal with Huntington's disease].

Berg T.

Tidsskr Nor Laegeforen. 2013 Oct 29;133(20):2167. doi: 10.4045/tidsskr.13.0878. Norwegian. No abstract available.

0

0

0

PUBMED

MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice.

Tomé S, Manley K, Simard JP, Clark GW, Slean MM, Swami M, Shelbourne PF, Tillier ER, Monckton DG, Messer A, Pearson CE.

PLoS Genet. 2013;9(2):e1003280. doi: 10.1371/journal.pgen.1003280.

0

0

0

PUBMED

Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.

Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, Liu D, Westervelt HK, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group..

J Huntingtons Dis. 2013;2(4):477-89. doi: 10.3233/JHD-130076.

0

0

0

PUBMED

Huntington's disease: underlying molecular mechanisms and emerging concepts.

Labbadia J, Morimoto RI.

Trends Biochem Sci. 2013 Aug;38(8):378-85. doi: 10.1016/j.tibs.2013.05.003. Review.

0

0

0

PUBMED

Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.

Doria JG, Silva FR, de Souza JM, Vieira LB, Carvalho TG, Reis HJ, Pereira GS, Dobransky T, Ribeiro FM.

Br J Pharmacol. 2013 Jun;169(4):909-21. doi: 10.1111/bph.12164.

0

0

0

PUBMED

Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study.

Dorsey ER, Brocht AF, Nichols PE, Darwin KC, Anderson KE, Beck CA, Singh S, Biglan KM, Shoulson I.

J Huntingtons Dis. 2013;2(4):509-15. doi: 10.3233/JHD-130071.

0

0

0

PUBMED

Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.

Mazarei G, Budac DP, Lu G, Adomat H, Tomlinson Guns ES, Möller T, Leavitt BR.

J Neurochem. 2013 Dec;127(6):852-67. doi: 10.1111/jnc.12350.

0

0

0

PUBMED

A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice.

Hölter SM, Stromberg M, Kovalenko M, Garrett L, Glasl L, Lopez E, Guide J, Götz A, Hans W, Becker L, Rathkolb B, Rozman J, Schrewed A, Klingenspor M, Klopstock T, Schulz H, Wolf E, Wursta W, Gillis T,

PLoS One. 2013 Nov 22;8(11):e80923. doi: 10.1371/journal.pone.0080923.

0

0

0

PUBMED

Genetic features of Huntington disease in Cuban population: implications for phenotype, epidemiology and predictive testing.

Vázquez-Mojena Y, Laguna-Salvia L, Laffita-Mesa JM, González-Zaldívar Y, Almaguer-Mederos LE, Rodríguez-Labrada R, Almaguer-Gotay D, Zayas-Feria P, Velázquez-Pérez L.

J Neurol Sci. 2013 Dec 15;335(1-2):101-4. doi: 10.1016/j.jns.2013.08.037.

0

0

0

PUBMED

Ethical issues and Huntington's disease.

Kromberg JG, Wessels TM.

S Afr Med J. 2013 Oct 11;103(12 Suppl 1):1023-6. doi: 10.7196/samj.7146.

0

0

0

PUBMED

Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models.

Marco S, Giralt A, Petrovic MM, Pouladi MA, Martínez-Turrillas R, Martínez-Hernández J, Kaltenbach LS, Torres-Peraza J, Graham RK, Watanabe M, Luján R, Nakanishi N, Lipton SA, Lo DC, Hayden MR, Alberc

Nat Med. 2013 Aug;19(8):1030-8. doi: 10.1038/nm.3246.

0

0

0

PUBMED

Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.

Brito V, Puigdellívol M, Giralt A, del Toro D, Alberch J, Ginés S.

Cell Death Dis. 2013 Apr 18;4:e595. doi: 10.1038/cddis.2013.116.

0

0

0

PUBMED

Genome-scale study of Huntington's disease identifies potential drug targets.

[No authors listed]

Pharmacogenomics. 2013 Jan;14(2):123. doi: 10.2217/pgs.12.209. No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy